Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | TACR1 | P25103 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19262510 | 0.85 | CYP2D6 (0.72) | CYP3A4CYP2D6TSHRTACR1MEN1 | |
| SCHEMBL11628726 | 0.85 | ADRB1 (0.56) | MEN1KMT2AALDH1A1CYP1A2ADRB1 | |
| SCHEMBL20676125 | 0.84 | CYP2D6 (0.70) | CYP3A4CYP2D6TSHRMEN1KMT2A | |
| SCHEMBL28322502 | 0.81 | CYP2D6 (0.48) | CYP3A4CYP2D6TSHRMEN1KMT2A | |
| SCHEMBL17320452 | 0.81 | CYP2D6 (0.59) | CYP3A4CYP2D6TSHRTACR1MEN1 | |
| SCHEMBL19262611 | 0.80 | CYP3A4 (0.61) | CYP3A4CYP2D6TSHRTACR1MEN1 | |
| SCHEMBL21571720 | 0.79 | MGLL (0.46) | CYP3A4CYP2D6TSHRMEN1KMT2A | |
| SCHEMBL28303845 | 0.78 | CYP2D6 (0.59) | CYP3A4CYP2D6TSHRMEN1KMT2A | |
| SCHEMBL16907553 | 0.78 | CYP2D6 (0.59) | CYP3A4CYP2D6TSHRMEN1KMT2A | |
| SCHEMBL28699525 | 0.78 | CYP3A4 (0.47) | CYP3A4CYP2D6TSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018093947-A1 | MAGL INHIBITORS | ABIDE THERAPEUTICS, INC. (US) | 2018-05-24 | — | — | WO | disclosed |